Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early targeted ibuprofen treatment for patent ductus arteriosus using a risk-based severity score
2015-004526-33Phase 3Completed
- Sponsor
- RCSI University of Medicine and Health Sciences
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in patent ductus arteriosus (PDA) comparing Early ibuprofen with Placebo (2 arms). Primary endpoint: Chronic lung disease and/or death. Started Dec 2015; status: completed.
02
Drugs
ibuprofen
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on 2015-004526-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004526-33.